1. OP05 Outcome of induction therapy with vedolizumab in children: Results from the prospective, multi-centre VEDOKIDS study. (21st January 2022) Authors: Shavit, Z; Stein, R; Aloi, M; Ledder, O; Focht, G; Urlep, D; Hyams, J; Broide, E; Vais, B; Levine, J; Shouval, D; Matar, M; Assa, A; Rosh, J; Hussey, S; Markowitz, J; Yerushalmy-Feler, A; Miele, E; Shaoul, R; Russell, R K Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i005 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P016 Colonoids derived from UC patients retain higher transcriptional response to inflammatory triggers in-vitro, even after several passages. (21st January 2022) Authors: Abbas Egbariya, H; Ben-Shoshan, M; Braun, Z; Berger, T; Granot, M; Loberman-Nachum, N; Vais, B; Gal Mor, O; Amir, A; Haberman, Y Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P210 Long-term outcome of very early onset inflammatory bowel disease associated with primary sclerosing cholangitis: a multicenter study from the Pediatric IBD Porto Group of ESPGHAN. (30th January 2023) Authors: Catassi, G; D'Arcangelo, G; Norsa, L; Bramuzzo, M; Hojsak, I; Kolho, K L; Romano, C; Gasparetto, M; Di Giorgio, A; Hussey, S; Yerushalmy-Feler, A; Turner, D; Matar, M; Vais, B; Karoliny, A; Alvisi, P; Tzivinikos, C; Aloi, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗